Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thepenier

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Annals of Hematology|July 24, 2012
Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapseJ V Malfuson, J Konopacki, C Thepenier, et al.
Cell Proliferation|April 13, 2011
Cell therapy of burnsT Leclerc, C Thepenier, P Jault, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Annals of Hematology|July 24, 2012
Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapseJ V Malfuson, J Konopacki, C Thepenier, et al.
Cell Proliferation|April 13, 2011
Cell therapy of burnsT Leclerc, C Thepenier, P Jault, et al.
Pageof 1